explore -WSS

explore

author：explore 2025-09-30 02:15:40 - browse：2346

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Brain worms: The science behind RFK Jr.'s parasitic infection

focus

WSS

Illinois to ban advertising for guns allegedly marketed to kids and militants

Brain worms: The science behind RFK Jr.'s parasitic infection

'The Exorcist' director William Friedkin dead at 87

Use wet bulb globe temperature, not heat index, to protect workers

H5N1 communication has been strictly for the birds

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Wikipedia

explore

hotspot

Bright Health sells Medicare Advantage business to Molina

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

After affirmative action ruling, medical educators look to 'holistic review'

Why workplace violence is so common in health care

ChatGPT in medicine: STAT answers readers' burning questions

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Walensky prepares to leave CDC — and Congress — behind

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Apple is now the first public company to be valued at $3 trillion

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

focus

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Trump Jan. 6 attorney John Lauro is ex

NYC plans to house migrants on an island in the East River

Medicare says breakthrough device reimbursement rule to come by summer

focus

focus

focus

explore